7-Methoxychromone

7-Methoxychromone

SCHEMBL1854902

COc1ccc2c(=O)ccoc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 1.00
FTO Q9C0B1 1/20 0.56
MAOB P27338 5/20 0.55
MAOA P21397 3/20 0.55
ALDH1A1 P00352 7/20 0.53
EPHX2 P34913 1/20 0.53
TNKS O95271 1/20 0.53
CYP19A1 P11511 1/20 0.53
MAPT P10636 4/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
POLB P06746 1/20 0.51
STAT1 P42224 1/20 0.51
HPGD P15428 5/20 0.51
CYP3A4 P08684 3/20 0.51
HSD17B10 Q99714 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
USP2 O75604 1/20 0.51
MAPK1 P28482 1/20 0.51
RECQL P46063 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
7-Methoxychromone SCHEMBL31260290 1.00 KDM4E (1.00) KDM4EFTOMAOBMAOAALDH1A1
7-Methoxychromone SCHEMBL28430247 0.94 KDM4E (0.88) KDM4EFTOMAOBMAOAALDH1A1
7-Methoxychromone SCHEMBL28423141 0.91 KDM4E (0.82) KDM4EFTOMAOBMAOAALDH1A1
7-Methoxychromone SCHEMBL28428762 0.89 KDM4E (0.80) KDM4EFTOMAOBMAOAALDH1A1
7-Methoxychromone SCHEMBL28428753 0.89 KDM4E (0.80) KDM4EFTOMAOBMAOAALDH1A1
Pentadecane SCHEMBL28423089 0.89 KDM4E (0.80) KDM4EFTOMAOBMAOAALDH1A1
SCHEMBL28124918 0.87 KDM4E (0.77) KDM4EFTOMAOBMAOAALDH1A1
SCHEMBL8871485 0.86 KDM4E (0.75) KDM4EMAOBMAOAALDH1A1MAPT
SCHEMBL6826684 0.83 KDM4E (0.71) KDM4EFTOMAOBMAOACYP19A1
SCHEMBL26661256 0.81 KDM4E (0.69) KDM4EFTOMAOBMAOAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113372318-A Preparation method and device of 7-methoxy-4' -methyl formate flavanone 贵州中医药大学 2021-09-10 CN claimed
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO claimed
JP-9188608-A None JP disclosed
EP-4474446-B1 ELECTROCHROMIC COMPOUNDS, COMPOSITIONS AND DEVICES COMPRISING THE SAME ESSILOR INT (FR) 2025-12-17 EP disclosed
WO-2025036382-A1 SULFONAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海复宏汉霖生物医药有限公司 2025-02-20 WO disclosed
CN-116120313-B Pyridoimidazole nitrogen fused ring compound and preparation method and application thereof 遵义医科大学 2025-02-11 CN disclosed
WO-2024251948-A1 ELECTROCHROMIC COMPOUNDS, COMPOSITIONS AND DEVICES COMPRISING THE SAME ESSILOR INTERNATIONAL (FR) 2024-12-12 WO disclosed
EP-4474446-A1 ELECTROCHROMIC COMPOUNDS, COMPOSITIONS AND DEVICES COMPRISING THE SAME Essilor International (FR) 2024-12-11 EP disclosed
CN-113999223-B Thiazole-containing flavonoid derivative, preparation method and application thereof 扬州大学 2023-12-19 CN disclosed
CN-116120313-A Pyridoimidazole nitrogen fused ring compound and preparation method and application thereof 遵义医科大学 2023-05-16 CN disclosed
CN-112759580-B Preparation method of chroman-4-one and derivatives thereof 河南大学 2022-05-17 CN disclosed
EP-1732913-A1 CHROMONE COMPLEXES MERCK PATENT GmbH (DE) 2006-12-20 EP disclosed
WO-2006128562-A1 USE OF CHROMONE DERIVATIVES MERCK PATENT GMBH (DE) 2006-12-07 WO disclosed
WO-2006094601-A1 CHROMEN-4-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2006-09-14 WO disclosed
EP-1656364-A1 CHROMEN-4-ONE DERIVATIVES MERCK PATENT GmbH (DE) 2006-05-17 EP disclosed
WO-2005097772-A1 CHROMONE COMPLEXES MERCK PATENT GMBH (DE) 2005-10-20 WO disclosed
WO-2005019197-A1 CHROMEN-4-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2005-03-03 WO disclosed
US-20050043398-A1 Use of chromen-4-one derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2005-02-24 US disclosed
EP-1508327-A1 Use of chromen-4-one derivatives for the care of skin and hair MERCK PATENT GmbH (DE) 2005-02-23 EP disclosed
JP-H09188608-A GREY HAIR PREVENTIVE AGENT KAO CORP 1997-07-22 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043398-A1 Use of chromen-4-one derivatives CYP8B1, CYP7B1, CYP2R1 KDM4E 1606/4885FTO 321/4885MAOB 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.